In mice implanted subcutaneously with the control cell line, RM1-LACZ, IL-18 neutralization resulted in significantly larger tumors (p = 0.0477) (Fig. 1 C), suggesting that endogenous IL-18 plays a role in tumor immunity. The gene discussed is IL18; the disease is neoplasm.